These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25702415)

  • 81. Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin?
    Pluta R; Bogucka-Kocka A; Ułamek-Kozioł M; Furmaga-Jabłońska W; Januszewski S; Brzozowska J; Jabłoński M; Kocki J
    Folia Neuropathol; 2015; 53(2):89-99. PubMed ID: 26216111
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery.
    Sharma HS
    J Neural Transm (Vienna); 2011 Jan; 118(1):3-6. PubMed ID: 21225296
    [No Abstract]   [Full Text] [Related]  

  • 83. Neuroprotective strategies against calpain-mediated neurodegeneration.
    Yildiz-Unal A; Korulu S; Karabay A
    Neuropsychiatr Dis Treat; 2015; 11():297-310. PubMed ID: 25709452
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Calpains and their endo- and exogenous regulators in various neurodegeneration models].
    Lysenko LA; Kantserova NP; Rendakov NL; Nemova NN
    Bioorg Khim; 2014; 40(6):695-702. PubMed ID: 25895366
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Calpain inhibition prevents amyloid-beta-induced neurodegeneration and associated behavioral dysfunction in rats.
    Granic I; Nyakas C; Luiten PG; Eisel UL; Halmy LG; Gross G; Schoemaker H; Möller A; Nimmrich V
    Neuropharmacology; 2010; 59(4-5):334-42. PubMed ID: 20650285
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
    Rao MV; Mohan PS; Peterhoff CM; Yang DS; Schmidt SD; Stavrides PH; Campbell J; Chen Y; Jiang Y; Paskevich PA; Cataldo AM; Haroutunian V; Nixon RA
    J Neurosci; 2008 Nov; 28(47):12241-54. PubMed ID: 19020018
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.
    Nixon RA; Saito KI; Grynspan F; Griffin WR; Katayama S; Honda T; Mohan PS; Shea TB; Beermann M
    Ann N Y Acad Sci; 1994 Dec; 747():77-91. PubMed ID: 7847693
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Calpain system dysregulation in rat brain at beta-amyloid-induced neurodegeneration].
    Lysenko LA; Kantserova NP; Rendakov NL; Sel'verova NB; Nemova NN
    Bioorg Khim; 2013; 39(5):572-8. PubMed ID: 25702415
    [TBL] [Abstract][Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.